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Introduction
Chronic osteomyelitis (COM) of the long bones is a com-
mon and debilitating condition in developing countries, par-
ticularly in Africa. Its management remains a challenge, and 
it is often a disease of the poor, commonly associated with 
malnutrition and compromised immunity. 
In Rwanda, patients with COM often present late due 
to cultural beliefs (in Kinyarwanda COM is inzibyi and be-
lieved to be curable by traditional healers). Other challenges 
contributing to late presentation include economic issues, 
inaccessible modern health care, lack of proper information 
from the local communities, and failure of diagnosis of acute 
osteomyelitis by health professionals at primary health cen-
tres. 
The key component of COM treatment is surgery to re-
move the dead bone, necrotic tissues, and purulent material 
from the medullary cavity of the bone.
The classical recommendation of postoperative antibiotic 
therapy for 4 to 6 weeks has poor compliance in our setting. 
Even the modified 3-week antibiotic course is often not ful-
ly complied with, for cultural and socioeconomic reasons. 
Furthermore, there is a logical scientific question regarding 
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the efficacy of long-course systemic antibiotic therapy, as the 
antibiotics hardly penetrate the COM bone site.  There is no 
published scientific evidence supporting the efficacy of the 
long-course of antibiotic therapy.1
Calcium sulfate plaster of Paris powder has been demon-
strated in experimental and clinical studies to be a suitable, 
biocompatible, and bioresorbable drug carrier.1 Antibiot-
ic-impregnated calcium sulfate beads have been demonstrat-
ed to provide an adequate local antibiotic concentration at 
the site of COM for 2 to 3 weeks.2
In this paper, we present the experience of locally made 
antibiotic-impregnated calcium sulfate pellets as local anti-
biotic therapy for COM at University Teaching Hospital of 
Butare (CHUB), Rwanda.
Methods
Locally made antibiotic-impregnated calcium 
sulfate pellets
Calcium sulfate powder was packed in small packs of 300 g 
and sterilized for use within the next 5 days. In the operating 
room, the calcium sulfate was mixed with diluted antibiotics. 
A sterile pack of 300 g of calcium sulfate was mixed with 2 
g of ceftriaxone and 480 mg of gentamycin. The quantity of 
powder used, and by consequence, the quantity of antibiotic 
depended on the estimated size of the bone defect after re-
moval of the sequestrum. We realized that it takes around 
1 to 2 hours for the pellets to be dry enough to be inserted 
into the bone defect. For this reason, the bone cement pellets 
were made before the preparation of the operating sites to 
allow enough time for the cement to dry (Figure 1). After 
surgery, all patients received similar parenteral antibiotics 
for 5 days.
Surgical procedure
The patients were operated on after receiving a definite di-
agnosis and providing written informed consent. The oper-
ations were carried out by 2 senior registrars with adequate 
experience in orthopaedic surgery. The surgical approaches 
depended on the affected bone. The affected bone was ex-
posed, and generally, a canoe was made to access the medul-
lary cavity (Figure 2).
The sequestrum was removed with all necrotic tissue in 
the cavity by generous bone curettage. After surgical toilet of 
the surgical site, the antibiotic-impregnated calcium sulfate 
pellets were inserted into the bone defect canoe (Figure 3 
and Figure 4).
Patients
The patients who consulted our surgical department from 
January 2015 to December 2016, and had a diagnosis of 
COM, were candidates for our study. During this period, 
65 patients underwent surgery for COM, 55 of whom were 
Table 1. Demographic characteristics
Age (years) n (%)
Sex
Male n (%) Female n (%)
0–15 31 (56) 19 12
16–30 18 (33%) 9 9
> 30 6 (11%) 6 0
Total 55 34 (62%) 21 (38%)









Figure 1.  Operating room-made calcium sulfate bone cement 
antibiotic-impregnated pellets
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enrolled in our study.  We excluded patients with second-
ary osteomyelitis and those for whom we estimated that the 
soft tissue covering of the bone might be challenging. Data 
collection was cumulatively done using a standardized ques-
tionnaire for every participant, and analysis was done using 
Microsft Excel.  After the procedure, there were 12 months of 
follow-up for all study patients.
Ethical considerations 
Approval for this study was obtained from the Department 
of Surgery Ethics Committee, and the Institutional Review 
Board of the University Teaching Hospital of Butare. The 
data collected was kept confidential, and only used for this 
study. All patients provided written informed consent before 
participating in the study. 
Results
From January 2015 to December 2016, 55 cases of COM 
were enrolled in this study and were followed up for 12 
months. Table 1 shows the demographic characteristics of 
our patients and Table 2 shows the affected bones.
Of the 55 cases of COM treated with locally made bone 
cement, 3 cases (5%) developed complications. Fifty-two 
cases (95%) improved without any complications after 12 
months of follow-up. Of the 3 cases with complications, 1 
case of COM of the right femur developed an early foreign 
body rejection reaction against the bone cement; this patient 
underwent additional surgery to remove the bone cement 
pellets on the fifth postoperative day.
The other 2 complications presented late as incomplete 
absorption of the calcium sulfate—1 case of COM of the left 
femur and another of the right tibia. They developed serous 
discharge after 3 and 4 months, respectively, and the fol-
low-up x-rays showed residual intramedullary calcium sul-
fate. The pellets were surgically removed.
Discussion
COM is a challenging and potentially lifelong condition. It is 
therefore essential to find strategies to eradicate the associat-
ed infectious organisms.
In this study, the majority of cases (56%) were paediatric 
cases under 15 years of age, and most of them were from 
the rural and low-income families. Poor hygiene and poor 
nutrition were possibly among the risk factors this patient 
population.
Our study also showed that the tibia was the most affect-
ed bone, with 45% of the cases, and that the tibia and the fe-
mur represented 80% of all cases. These results are consistent 
with other studies.3–5
In COM, the infected bone becomes devascularized and 
eventually sequestered as a portion of dead bone that con-
tains bacterial colonies.6
Dead bone tissues with an insufficient blood supply in-
terfere with normal healing and must be surgically removed.6
Appropriate antibiotic therapy supplements surgery. 
However, the site of infected bone often has impaired vas-
culature, and as a consequence, the antibiotic levels achieved 
following systemic administration may be much lower than 
expected, relative to the serum or the surrounding tissue lev-
els.6
Intravenous or oral antibiotics for 4 to 6 weeks is a widely 
used protocol to treat COM.1 This duration of therapy re-
mains empirical rather than evidence-based, as there are no 
documented records or publications indicating its superiori-
ty over other protocols.1
One good alternative for antibiotic therapy in COM is 
the use of a local antibiotic spacer. Antibiotic-impregnated 
bone cement was introduced in the 1970s to treat infected 
arthroplasties, and antibiotic-impregnated beads have since 
been developed to treat local soft tissue and bone infec-
tions.1,2 The advantage of antibiotic-containing beads is that 
they fill the dead space produced by sequestrectomy and 
bone curettage and the resulting local antibiotic concentra-
tions vastly exceed the minimum inhibitory concentrations 
for most pathogens isolated in orthopaedic infections.1,2,6–12
Calcium sulfate can be loaded with antibiotics and used 
as a biodegradable medication delivery device. The advan-
tage of calcium sulfate pellets is that they can offer the chance 
for delivery and sufficient concentrations of local antibiotics. 
With the biodegradation, they do not need to be surgically 
removed.2,6,8,11
Commercially manufactured bone cement is too expen-
sive for the Rwandan population and probably for most of 
the African population. Additionally, it is not readily avail-
able in our market. In 2012, a manufacturing company from 
Europe tried to implement a bone cement protocol in Rwan-
da. Only 20 cases were successfully treated (unpublished 
data), and the protocol was stopped due to high costs that 
could not be met by our population. One set costs approx-
imately US$200, and some cases would need 4 to 5 sets of 
commercially manufactured bone cement to fill the bone de-
fect after sequestrectomy.
Figure 2. A canoe made in the 
tibia to access and remove 
the sequestrum and other 
necrotic tissues; this image 
shows the bone defect 
(canoe) after curettage.
Figure 3. The antibiotic-
impregnated calcium sulfate 
bone cement pellets filling 
the bone defect (canoe) 
after sequestrectomy.
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Our experience, however, showed that calcium sulfate 
antibiotic-impregnated bone cement can be easily and safely 
made locally, providing a sound and sustainable option for 
localized antibiotic delivery in our setting. 
There were, however, a few drawbacks. The degrada-
tion products of calcium sulfate carriers generally resulted 
in persistent drainage from the wound, and this may ag-
gravate deep infections. Calcium sulfate absorbs plenty of 
water, which subsequently promotes seroma formation and 
increases the risk of secondary infection.2 Our experience 
also showed that the calcium sulfate might not be completely 
degraded, causing a foreign body reaction in a small number 
of cases.
Conclusions
Our study showed that COM is more frequent in paediatric 
patients with a risk of permanent sequelae. Locally made an-
tibiotic-impregnated bone cement pellets were a safe, effec-
tive, and low-cost option for COM treatment in the Rwan-
dan tertiary hospital setting.
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Figure 4. Postoperative tibia control x-ray images 
showing bone cement pellets filling the bone defect after 
sequestrectomy
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